# Prenetics Global Limited (PRE)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Price:** $19.25 (-8.03%)

> Prenetics Global Limited is a health sciences company headquartered in Hong Kong that specializes in early detection, prevention, and treatment of diseases, particularly cancer, through genomic testing and wellness solutions. The company operates three primary business segments: Prevention, through CircleDNA, a direct-to-consumer genetic testing brand utilizing next-generation sequencing technology to provide comprehensive health and wellness insights; Diagnostics, through ACT Genomics, which offers precision oncology testing services and became the first Asia-based company to receive FDA clearance for comprehensive genomic profiling of solid tumors; and Consumer Health, featuring IM8 Health, a supplement and wellness brand, and Europa, a sports nutrition distribution company. Prenetics' consumer DNA tests use whole-exome sequencing, providing significantly more genetic data than traditional array-based methods. The company distributes its products globally through retail partnerships, online platforms, and healthcare providers across Hong Kong, Taiwan, the United States, and other international markets, serving individual consumers, healthcare professionals, and institutions seeking science-backed solutions for health optimization and disease management.

Financial data not yet available for this company.

Source: [CompaniesByCap](https://companiesbycap.com/company/PRE)